Joseph N M.

ReferralMD delivers proven referral management, provider search and e-consult solutions that help hospitals, health systems, payers, and pharma match patients with the providers best suited to care for them. The SmartMATCH suite of solutions—for consumers, access centers, and referral networks—enables a consistent patient experience across multiple points of access, helping close the feedback loop with receiving and referring providers. The company’s proprietary provider data management platform coupled with workflow, fax management tools, and clinical decision support for administrators helps improve revenue, reduce leakage, and lower costs. VALUE FOR STAKEHOLDERS: - Provide immediate improvement in revenue for healthcare stakeholders and offer demonstrable, repeatable, significant, short and long-term cost savings. - Improve patient access and outcomes by routing patients to the most appropriate doctor based on cost and quality data - Build and maintain a strong referral network for improved customer service and revenue growth - Enhance private practice provider relationships to prevent referral leakage - Gain insight into referral patterns for optimal patient experience and repeat business ReferralMD delivers proven referral and consult management, patient access and communications and PRM/CRM marketing solutions which help hospitals, health systems, networks, and payers streamline the referral process, decrease patient leakage and improve communication between providers and patients. With powerful clinical decision support tools and real-time analytics, ReferralMD helps healthcare providers increase revenue, drive operational efficiencies and improve customer service. To learn more about ReferralMD, please visit http://www.getreferralmd.com.

Noninvasix will be the first company to monitor the severity of sepsis and septic shock non-invasively, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real time. Incorporating Noninvasix into the ICU workflow allows clinicians to more quickly and accurately diagnose critically ill patients and tailor treatments to improve outcomes. Future developments, enhancements, and evidence will expand our technology's use and clinical impact in other indications and settings. Noninvasix is backed by 15 years of optoacoustic research and more than $6.5 million in research grants.

Green Sun Medical LLC. is a Colorado company dedicated to developing transformative bracing technology to prevent spinal deformity surgery. We have assembled a world class surgeon advisory board of scoliosis thought leaders and veteran industry executives. Our tech enabled dynamic brace will provide precise corrective pressure to patients. For the first time ever, physicians will be able to monitor the performance of a brace in real-time.

Founded in 2013, VICIS'​ mission is to minimize the impact of sports-related head injuries. Harnessing novel technologies and insights from the latest medical research, the company designs and develops headgear that improves protection and performance for athletes of all ages.

Sensulin, LLC is a diabetes drug discovery company. We are developing a true once-a-day glucose-responsive insulin, that may mimic a healthy human pancreas. Sensulin™ may eliminate the need for basal & prandial insulin, offer a substantial improvement in the standard of care, and most importantly, give those with diabetes a chance at a normal life.

Sensulin, LLC is a diabetes drug discovery company. We are developing a true once-a-day glucose-responsive insulin, that may mimic a healthy human pancreas. Sensulin™ may eliminate the need for basal & prandial insulin, offer a substantial improvement in the standard of care, and most importantly, give those with diabetes a chance at a normal life.

Were transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio

Cureus (Part of Springer Nature) is an online, Open Access multi-specialty medical journal that publishes and promotes medical knowledge from around the world. Join our rapidly growing audience to discuss articles with their authors, assign supplementary post-publication review scores and browse peer-reviewed articles across more than 60 medical specialties. Sign up for your free Cureus account today and help us revolutionize how medical knowledge is published, accessed, and shared.

ReferralMD delivers proven referral management, provider search and e-consult solutions that help hospitals, health systems, payers, and pharma match patients with the providers best suited to care for them. The SmartMATCH suite of solutions—for consumers, access centers, and referral networks—enables a consistent patient experience across multiple points of access, helping close the feedback loop with receiving and referring providers. The company’s proprietary provider data management platform coupled with workflow, fax management tools, and clinical decision support for administrators helps improve revenue, reduce leakage, and lower costs. VALUE FOR STAKEHOLDERS: - Provide immediate improvement in revenue for healthcare stakeholders and offer demonstrable, repeatable, significant, short and long-term cost savings. - Improve patient access and outcomes by routing patients to the most appropriate doctor based on cost and quality data - Build and maintain a strong referral network for improved customer service and revenue growth - Enhance private practice provider relationships to prevent referral leakage - Gain insight into referral patterns for optimal patient experience and repeat business ReferralMD delivers proven referral and consult management, patient access and communications and PRM/CRM marketing solutions which help hospitals, health systems, networks, and payers streamline the referral process, decrease patient leakage and improve communication between providers and patients. With powerful clinical decision support tools and real-time analytics, ReferralMD helps healthcare providers increase revenue, drive operational efficiencies and improve customer service. To learn more about ReferralMD, please visit http://www.getreferralmd.com.

Noninvasix will be the first company to monitor the severity of sepsis and septic shock non-invasively, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real time. Incorporating Noninvasix into the ICU workflow allows clinicians to more quickly and accurately diagnose critically ill patients and tailor treatments to improve outcomes. Future developments, enhancements, and evidence will expand our technology's use and clinical impact in other indications and settings. Noninvasix is backed by 15 years of optoacoustic research and more than $6.5 million in research grants.